HOME >> BIOLOGY >> NEWS
Tracking diseases by bait, plane, insects and fowl

The 91st Ecological Society of America Annual Meeting will be held in Memphis, Tennessee, from August 6 -11, 2006. The theme of the meeting is "Icons and Upstarts in Ecology" and some 3,000 scientists are expected to attend. Below is a sampling of papers, focusing on diseases, which will be presented during the week. Other topics to be covered during the meeting include marine ecology, environmental justice, climate change, biogeochemistry, and invasive species.

Human-mediated spread of Amphibian Pathogens through the Tiger Salamander Bait Trade Monday, August 7, 8 - 11:30 AM Plantation Room, Cook Convention Center

Emerging infectious diseases are implicated in the declines of amphibians worldwide. One virus in particular, ranavirus, has been associated with die-offs in wild amphibian populations in North America, Europe, Australia, and South America, and in commercial populations in Asia. Researching the pathogens' movements through the tiger salamander bait trade in Arizona, Angela Picco (Arizona State University) found 62 percent of bait shops carried infected animals. Picco will discuss the findings during a contributed oral session on amphibian and reptile ecology and decline.

Pandemic Diseases and the Aviation Network Tuesday August 8, 1:30 - 5:00 PM, L-4, Cook Convention Center

Lars Hufnagel (University of California Santa Barbara) and colleagues designed a method to track the spread of infectious diseases through the global aviation network. Focusing on international and national civil aviation traffic, the researchers incorporated the SARS (Severe Acute Respiratory Syndrome) outbreaks, comparing their data with actual reported cases. Hufnagel and colleagues found good agreement between what the model suggested and what actually happened, suggesting their model can be used to help predict future worldwide spread of diseases and to identify high-risk regions in advance. Hufnagel will report
'"/>

Contact: Annie Drinkard
annie@esa.org
Ecological Society of America
1-Aug-2006


Page: 1 2 3

Related biology news :

1. Gut check: Tracking the ecosystem within us
2. Tracking genes for self-pollination in arabidopsis
3. Tracking sperm whales and jumbo squid
4. Tracking membranes of rupturing blood cells sheds light on malaria infection
5. Tracking a killer: Observing liver invasion by malarial parasites
6. Tracking orangutans from the sky
7. Female gender provides an advantage in renal diseases
8. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
9. News conference on plant diseases and issues important to California
10. Plant diseases and issues that are of importance to Californias economy and agriculture
11. Inflammation is at the origin and progression of diseases such as diabetes or cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tracking diseases bait plane insects and fowl

(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: